Delivery Order SPE2DB22D2218-SPE2DB25FR2KS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,372.29 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, awarded on August 4, 2025, represents a non-competitive set-aside contract and is scheduled for completion by August 5, 2025. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $15,723.83 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The delivery will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $38,749.42 for the supply of DESCOVY 200-25 mg tablets (30-count units) under a firm fixed-price contract with the Department of Defense Medical Supply Chain. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, and represents a competitively awarded, non-set-aside procurement. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,354.64 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The U.S. Department of Defense Medical Supply Chain awarded a $20,959.22 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity 30 units). This competitive, non-set-aside contract features firm fixed pricing and carries an ultimate completion date of June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,030.67 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of DESCOVY 200-25 mg tablets (quantity: 30 units). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $32,034.58 on May 12, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 13, 2025. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,303.18 on August 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $62K to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR2KSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,639.01 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award falls under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a critical vendor for federal medical procurement, demonstrating consistent capability to fulfill competitive federal pharmaceutical supply requirements across multiple therapeutic domains. The company's federal contract portfolio includes deliveries of diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for DESCOVY, an antiretroviral medication, aligns with the company's established role as a primary pharmaceutical supplier within the military's healthcare supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 4/29/25 |